PRLD – prelude therapeutics incorporated (US:NASDAQ)
Stock Stats
News
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor [Yahoo! Finance]
Prelude Therapeutics Receives FDA Clearance of Investigational New Drug Application (IND) for PRT12396, a Mutant-selective JAK2V617F Inhibitor
Prelude Therapeutics (NASDAQ:PRLD) was downgraded by analysts at Wall St
Prelude Therapeutics (NASDAQ:PRLD) was upgraded by analysts at Wall Stre
Prelude Therapeutics Incorporated's (NASDAQ:PRLD) Path To Profitability [Yahoo! Finance]
Form 4 Prelude Therapeutics For: Feb 04 Filed by: Combs Andrew
Form 4 Prelude Therapeutics For: Feb 04 Filed by: Scherle Peggy
Form 4 Prelude Therapeutics For: Feb 04 Filed by: Lim Bryant David
Form 4 Prelude Therapeutics For: Feb 04 Filed by: Vaddi Krishna
Form 8-K Prelude Therapeutics For: Jan 29
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.